Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes

IF 7.6 2区 医学 Q1 HEMATOLOGY HemaSphere Pub Date : 2024-04-22 DOI:10.1002/hem3.71
Heiko Müller, Frank Dicker, Constance Bär, Wencke Walter, Stephan Hutter, Niroshan Nadarajah, Manja Meggendorfer, Qingsong Gao, Ilaria Iacobucci, Charles G. Mullighan, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
{"title":"Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes","authors":"Heiko Müller,&nbsp;Frank Dicker,&nbsp;Constance Bär,&nbsp;Wencke Walter,&nbsp;Stephan Hutter,&nbsp;Niroshan Nadarajah,&nbsp;Manja Meggendorfer,&nbsp;Qingsong Gao,&nbsp;Ilaria Iacobucci,&nbsp;Charles G. Mullighan,&nbsp;Wolfgang Kern,&nbsp;Torsten Haferlach,&nbsp;Claudia Haferlach","doi":"10.1002/hem3.71","DOIUrl":null,"url":null,"abstract":"<p>We report the analysis of 379 cases of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) using whole-transcriptome sequencing data (Table S1 and Supporting Information S1: Methods). In 48 adult, 36 pediatric, and 37 infant cases of BCP-ALL carrying t(4;11)(q21;q23)/<i>KMT2A::AFF1</i> rearrangements (KMT2A-r), we observed strongly favored usage of proximal IGHV genes in V(D)J recombination and more abundant de novo DJ<sub>H</sub> recombination than in other BCP-ALL subtypes. This finding has implications for the detection of measurable residual disease (MRD) in clinical practice as MRD-guided treatment choices have proved to provide valuable guidance in a disease that is still associated with poor prognosis in all age categories.</p><p>BCP-ALL carrying KMT2A-r is an aggressive leukemia with poor prognosis characterized by the sudden occurrence of very high white blood cell counts, a slight preference for female patients, rapid progression, and significantly shorter survival than KMT2A-r-negative patients.<span><sup>1, 2</sup></span> Treatment options that significantly prolong the survival of affected patients are limited to allogeneic stem cell transplantation.<span><sup>2</sup></span> The incidence of KMT2A-r BCP-ALL is estimated between 4% and 10% in adults and 3% and 4% in childhood.<span><sup>3</sup></span></p><p>KMT2A is a histone methyl transferase of the trithorax group involved in the establishment of epigenetic memory. It catalyzes H3K4 methylation of a large number of physiological targets including HOX genes, supporting activation of their expression.<span><sup>4, 5</sup></span> In leukemogenic fusions, the N-terminal portion of <i>KMT2A</i> is fused in frame to more than 100 fusion partners.<span><sup>6</sup></span> In the fusion product, the catalytic SET domain of KMT2A is lost. The most frequently observed fusion partners favor the interaction of the fusion product with another histone methyl transferase (DOT1L) that catalyzes H3K79 methylation. As a consequence, proper regulation of target genes activated in this aberrant fashion appears to be disturbed in cells carrying KMT2A-r.<span><sup>4, 5, 7, 8</sup></span></p><p>Proximally biased V(D)J recombination was first described in pre-B-cell lines<span><sup>9</sup></span> and later shown to depend on <i>Pax5</i> function.<span><sup>10</sup></span> It is now understood that the generation of a randomized immunoglobulin repertoire depends on chromatin modifications at the IGH locus controlled by <i>PAX5</i> and its target, <i>WAPL</i>.<span><sup>11, 12</sup></span> In addition to classical V(D)J recombination,<span><sup>13</sup></span> B-cell receptors (BCRs) are known to be modified by direct V<sub>H</sub> to V<sub>H</sub>DJ<sub>H</sub> recombination (V<sub>H</sub> replacement)<span><sup>14, 15</sup></span> and this process is known to occur also in BCP-ALL cells.<span><sup>16-18</sup></span> Whether the relative contribution of V(D)J recombination and V<sub>H</sub> replacement to clonal evolution of BCRs displays BCP-ALL subtype specificity is currently a matter of investigation.<span><sup>19, 20</sup></span></p><p>During the analysis of BCR rearrangements in RNA-sequencing (RNA-Seq) data from BCP-ALL samples, we noticed an unusual abundance of rearrangements involving <i>IGHV6-1</i> in samples carrying KMT2A-r fusion genes. To quantify this observation, we employed MiXCR analysis of RNA-Seq reads (Figure 1). The number of RNA-Seq reads mapping to a particular IGHV gene by MiXCR was used to quantify the expression levels of individual IGHV genes in a sample. The heatmap in Figure 1 shows the results of this analysis. In this heatmap, the IGHV genes are ordered according to their proximity in terms of genomic distance to the cluster of DJ<sub>H </sub>segments in the IGH locus. While for most samples, the expression level of IGHV genes appears to be independent of their genomic position, in KMT2A-r samples the most proximal IGHV gene IGHV6-1 displays significantly higher expression levels as compared to distal ones. This observation is true for KMT2A-r samples of all age classes.</p><p>We employed junction analysis of MiXCR-derived nucleotide sequences of rearranged IGH alleles to test whether there are BCP-ALL-subtype-specific differences in V(D)J recombination. IMGT-V-QUEST was used for this purpose, which identifies as junctions the nucleotides coding for the amino acids encompassing the anchor positions of the CDR3 region (C104-W118) and maps the nucleotides to the V<sub>H</sub>-N-D-N-J<sub>H</sub> components of the CDR3 region (Table S2). The results are shown in Figure 2. We observed that KMT2A-r samples of all age classes have a median number of three DNJ<sub>H</sub> stems per sample (Figure 2A). The only subtype with a similar median number of DNJ<sub>H</sub> stems per sample is <i>t(1;19)/TCF3::PBX1</i>. At the other end of the spectrum is the <i>DUX4</i> subtype where multiple DNJ<sub>H</sub> stems per sample were not detected. Furthermore, the CDR3 regions at the nucleotide level identified in KMT2A-r samples are shorter than in most other BCP-ALL subtypes (Figure 2B).</p><p>We conclude that V(D)J recombination is proximally biased in samples with KMT2A-r of all age classes. Proximally biased V(D)J recombination leads to preferential usage of <i>IGHV6-1</i> in BCR rearrangements. Indeed, up to 50% of samples with KMT2A-r harbor BCRs involving <i>IGHV6-1</i>.</p><p>We detected subtype specificity in the clonal evolution of BCP-ALL. We observed more DNJ<sub>H</sub> stems in KMT2A-r samples as compared to other types of BCP-ALL, and the CDR3 regions in KMT2A-r samples are shorter. This is in line with the observations reported by Darzentas et al.,<span><sup>19, 20</sup></span> who reported a detailed analysis of clonal evolution in adult BCP-ALL with different contributions of de novo V(D)J recombination and V<sub>H</sub> replacement in different BCP-ALL subtypes. V<sub>H</sub> replacement can occur repeatedly leading to prolonged CDR3 regions due to footprint nucleotides left behind at each V<sub>H</sub> replacement step located between the canonical and the cryptic recombination signal sequence.<span><sup>20</sup></span> The present study extends the observation of proximally biased clonal evolution to cases of infant and pediatric BCP-ALL carrying KMT2A-r.</p><p>DJ<sub>H</sub> recombination is the first step in V(D)J recombination<span><sup>13</sup></span> and the realization of a fully randomized immunoglobulin repertoire is dependent on IGH locus decontraction controlled by <i>PAX5</i> and <i>WAPL</i>.<span><sup>11, 12</sup></span> Therefore, both the more frequent occurrence of de novo DJ<sub>H</sub> recombination as well as the proximal bias in V(D)J recombination suggest a more primitive stage of differentiation of KMT2A-r BCP-ALL. These findings have implications for the clinical management of KMT2A-r BCP-ALL cases as clonal evolution interferes with reliable detection of MRD based on IG rearrangements. An obvious alternative would be the detection of fusion products and co-mutations.</p><p>Heiko Müller performed the analyses and wrote the manuscript. Wencke Walter, Stephan Hutter, Niroshan Nadarajah, and Manja Meggendorfer generated the NGS data. Constance Bär and Frank Dicker contributed expertise in BCR rearrangement analyses. Qingsong Gao, Ilaria Iacobucci, and Charles G. Mullighan provided the WTS data for the validation cohort. Wolfgang Kern, Torsten Haferlach, and Claudia Haferlach supervised and coordinated the research. All authors read and approved the final version of the manuscript.</p><p>Torsten Haferlach, Claudia Haferlach, and Wolfgang Kern declare part ownership of Munich Leukemia Laboratory (MLL). Heiko Müller, Frank Dicker, Constance Bär, Wencke Walter, Stephan Hutter, Niroshan Nadarajah, and Manja Meggendorfer are employed by the MLL. Charles G. Mullighan received research funding from Loxo Oncology, Pfizer, AbbVie; honoraria from Amgen and Illumina, and holds stock in Amgen.</p><p>This study was supported by the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and NCI Grant R35 CA197695 (to C. G. M.).</p>","PeriodicalId":12982,"journal":{"name":"HemaSphere","volume":null,"pages":null},"PeriodicalIF":7.6000,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hem3.71","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HemaSphere","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hem3.71","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We report the analysis of 379 cases of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) using whole-transcriptome sequencing data (Table S1 and Supporting Information S1: Methods). In 48 adult, 36 pediatric, and 37 infant cases of BCP-ALL carrying t(4;11)(q21;q23)/KMT2A::AFF1 rearrangements (KMT2A-r), we observed strongly favored usage of proximal IGHV genes in V(D)J recombination and more abundant de novo DJH recombination than in other BCP-ALL subtypes. This finding has implications for the detection of measurable residual disease (MRD) in clinical practice as MRD-guided treatment choices have proved to provide valuable guidance in a disease that is still associated with poor prognosis in all age categories.

BCP-ALL carrying KMT2A-r is an aggressive leukemia with poor prognosis characterized by the sudden occurrence of very high white blood cell counts, a slight preference for female patients, rapid progression, and significantly shorter survival than KMT2A-r-negative patients.1, 2 Treatment options that significantly prolong the survival of affected patients are limited to allogeneic stem cell transplantation.2 The incidence of KMT2A-r BCP-ALL is estimated between 4% and 10% in adults and 3% and 4% in childhood.3

KMT2A is a histone methyl transferase of the trithorax group involved in the establishment of epigenetic memory. It catalyzes H3K4 methylation of a large number of physiological targets including HOX genes, supporting activation of their expression.4, 5 In leukemogenic fusions, the N-terminal portion of KMT2A is fused in frame to more than 100 fusion partners.6 In the fusion product, the catalytic SET domain of KMT2A is lost. The most frequently observed fusion partners favor the interaction of the fusion product with another histone methyl transferase (DOT1L) that catalyzes H3K79 methylation. As a consequence, proper regulation of target genes activated in this aberrant fashion appears to be disturbed in cells carrying KMT2A-r.4, 5, 7, 8

Proximally biased V(D)J recombination was first described in pre-B-cell lines9 and later shown to depend on Pax5 function.10 It is now understood that the generation of a randomized immunoglobulin repertoire depends on chromatin modifications at the IGH locus controlled by PAX5 and its target, WAPL.11, 12 In addition to classical V(D)J recombination,13 B-cell receptors (BCRs) are known to be modified by direct VH to VHDJH recombination (VH replacement)14, 15 and this process is known to occur also in BCP-ALL cells.16-18 Whether the relative contribution of V(D)J recombination and VH replacement to clonal evolution of BCRs displays BCP-ALL subtype specificity is currently a matter of investigation.19, 20

During the analysis of BCR rearrangements in RNA-sequencing (RNA-Seq) data from BCP-ALL samples, we noticed an unusual abundance of rearrangements involving IGHV6-1 in samples carrying KMT2A-r fusion genes. To quantify this observation, we employed MiXCR analysis of RNA-Seq reads (Figure 1). The number of RNA-Seq reads mapping to a particular IGHV gene by MiXCR was used to quantify the expression levels of individual IGHV genes in a sample. The heatmap in Figure 1 shows the results of this analysis. In this heatmap, the IGHV genes are ordered according to their proximity in terms of genomic distance to the cluster of DJsegments in the IGH locus. While for most samples, the expression level of IGHV genes appears to be independent of their genomic position, in KMT2A-r samples the most proximal IGHV gene IGHV6-1 displays significantly higher expression levels as compared to distal ones. This observation is true for KMT2A-r samples of all age classes.

We employed junction analysis of MiXCR-derived nucleotide sequences of rearranged IGH alleles to test whether there are BCP-ALL-subtype-specific differences in V(D)J recombination. IMGT-V-QUEST was used for this purpose, which identifies as junctions the nucleotides coding for the amino acids encompassing the anchor positions of the CDR3 region (C104-W118) and maps the nucleotides to the VH-N-D-N-JH components of the CDR3 region (Table S2). The results are shown in Figure 2. We observed that KMT2A-r samples of all age classes have a median number of three DNJH stems per sample (Figure 2A). The only subtype with a similar median number of DNJH stems per sample is t(1;19)/TCF3::PBX1. At the other end of the spectrum is the DUX4 subtype where multiple DNJH stems per sample were not detected. Furthermore, the CDR3 regions at the nucleotide level identified in KMT2A-r samples are shorter than in most other BCP-ALL subtypes (Figure 2B).

We conclude that V(D)J recombination is proximally biased in samples with KMT2A-r of all age classes. Proximally biased V(D)J recombination leads to preferential usage of IGHV6-1 in BCR rearrangements. Indeed, up to 50% of samples with KMT2A-r harbor BCRs involving IGHV6-1.

We detected subtype specificity in the clonal evolution of BCP-ALL. We observed more DNJH stems in KMT2A-r samples as compared to other types of BCP-ALL, and the CDR3 regions in KMT2A-r samples are shorter. This is in line with the observations reported by Darzentas et al.,19, 20 who reported a detailed analysis of clonal evolution in adult BCP-ALL with different contributions of de novo V(D)J recombination and VH replacement in different BCP-ALL subtypes. VH replacement can occur repeatedly leading to prolonged CDR3 regions due to footprint nucleotides left behind at each VH replacement step located between the canonical and the cryptic recombination signal sequence.20 The present study extends the observation of proximally biased clonal evolution to cases of infant and pediatric BCP-ALL carrying KMT2A-r.

DJH recombination is the first step in V(D)J recombination13 and the realization of a fully randomized immunoglobulin repertoire is dependent on IGH locus decontraction controlled by PAX5 and WAPL.11, 12 Therefore, both the more frequent occurrence of de novo DJH recombination as well as the proximal bias in V(D)J recombination suggest a more primitive stage of differentiation of KMT2A-r BCP-ALL. These findings have implications for the clinical management of KMT2A-r BCP-ALL cases as clonal evolution interferes with reliable detection of MRD based on IG rearrangements. An obvious alternative would be the detection of fusion products and co-mutations.

Heiko Müller performed the analyses and wrote the manuscript. Wencke Walter, Stephan Hutter, Niroshan Nadarajah, and Manja Meggendorfer generated the NGS data. Constance Bär and Frank Dicker contributed expertise in BCR rearrangement analyses. Qingsong Gao, Ilaria Iacobucci, and Charles G. Mullighan provided the WTS data for the validation cohort. Wolfgang Kern, Torsten Haferlach, and Claudia Haferlach supervised and coordinated the research. All authors read and approved the final version of the manuscript.

Torsten Haferlach, Claudia Haferlach, and Wolfgang Kern declare part ownership of Munich Leukemia Laboratory (MLL). Heiko Müller, Frank Dicker, Constance Bär, Wencke Walter, Stephan Hutter, Niroshan Nadarajah, and Manja Meggendorfer are employed by the MLL. Charles G. Mullighan received research funding from Loxo Oncology, Pfizer, AbbVie; honoraria from Amgen and Illumina, and holds stock in Amgen.

This study was supported by the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital and NCI Grant R35 CA197695 (to C. G. M.).

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
各年龄段 KMT2A::AFF1 BCP-ALL 中 IGH 等位基因克隆进化过程中的近端偏向 V(D)J 重组
我们利用全转录组测序数据分析了 379 例 B 细胞前体急性淋巴细胞白血病(BCP-ALL)病例(表 S1 和辅助信息 S1:方法)。在携带t(4;11)(q21;q23)/KMT2A::AFF1重排(KMT2A-r)的48例成人、36例儿科和37例婴儿BCP-ALL病例中,我们观察到与其他BCP-ALL亚型相比,近端IGHV基因在V(D)J重组中的使用受到强烈青睐,而新生DJH重组则更为丰富。携带 KMT2A-r 的 BCP-ALL 是一种侵袭性白血病,预后较差,其特点是突然出现极高的白细胞计数,女性患者略占优势,病情进展迅速,生存期明显短于 KMT2A-r 阴性患者、2 据估计,KMT2A-r BCP-ALL 在成人中的发病率为 4% 至 10%,在儿童中的发病率为 3% 至 4%。3KMT2A 是一种三轴组蛋白甲基转移酶,参与表观遗传记忆的建立。它催化包括 HOX 基因在内的大量生理靶标的 H3K4 甲基化,从而支持这些靶标的表达激活。4, 5 在致白血病融合中,KMT2A 的 N 端部分与 100 多个融合伙伴进行框架融合。在融合产物中,KMT2A 的催化 SET 结构域消失了。最常见的融合伙伴有利于融合产物与催化 H3K79 甲基化的另一种组蛋白甲基转移酶(DOT1L)相互作用。因此,在携带 KMT2A-r 的细胞中,以这种异常方式激活的靶基因的正常调控似乎受到了干扰。4、5、7、8近端偏向的 V(D)J 重组首先在前 B 细胞系中被描述9 ,后来被证明依赖于 Pax5 的功能10 。现在的理解是,随机免疫球蛋白复合物的产生依赖于由 PAX5 及其靶标 WAPL 控制的 IGH 基因座的染色质修饰11、12 除经典的 V(D)J 重组13 外,已知 B 细胞受体(BCR)可通过 VH 与 VHDJH 的直接重组(VH 置换)14、15 进行修饰,而且已知 BCP-ALL 细胞中也会发生这一过程。在分析 BCP-ALL 样本 RNA 序列(RNA-Seq)数据中的 BCR 重排时,我们注意到在携带 KMT2A-r 融合基因的样本中,涉及 IGHV6-1 的重排异常丰富。为了量化这一观察结果,我们对 RNA-Seq 读数进行了 MiXCR 分析(图 1)。通过MiXCR分析映射到特定IGHV基因的RNA-Seq读数数量可用于量化样本中单个IGHV基因的表达水平。图1中的热图显示了这一分析的结果。在该热图中,IGHV 基因按其与 IGH 基因座中 DJH 片段群的基因组距离远近排序。虽然对大多数样本来说,IGHV基因的表达水平似乎与其基因组位置无关,但在KMT2A-r样本中,最邻近的IGHV基因IGHV6-1的表达水平明显高于远端基因。我们对重排的IGH等位基因的MiXCR衍生核苷酸序列进行了连接分析,以检验V(D)J重组是否存在BCP-ALL亚型特异性差异。IMGT-V-QUEST用于这一目的,它将编码CDR3区域锚位置(C104-W118)氨基酸的核苷酸识别为连接点,并将这些核苷酸映射到CDR3区域的VH-N-D-N-JH成分上(表S2)。结果如图 2 所示。我们观察到,所有年龄段的 KMT2A-r 样本中,每个样本都有三个 DNJH 茎(图 2A)。每个样本的 DNJH 茎中位数相似的唯一亚型是 t(1;19)/TCF3::PBX1。另一端是 DUX4 亚型,该亚型每个样本未检测到多个 DNJH 茎。此外,在 KMT2A-r 样本中发现的核苷酸水平的 CDR3 区域比大多数其他 BCP-ALL 亚型的 CDR3 区域短(图 2B)。近端偏向的V(D)J重组导致IGHV6-1在BCR重排中的优先使用。事实上,多达50%的KMT2A-r样本都含有涉及IGHV6-1的BCR。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
HemaSphere
HemaSphere Medicine-Hematology
CiteScore
6.10
自引率
4.50%
发文量
2776
审稿时长
7 weeks
期刊介绍: HemaSphere, as a publication, is dedicated to disseminating the outcomes of profoundly pertinent basic, translational, and clinical research endeavors within the field of hematology. The journal actively seeks robust studies that unveil novel discoveries with significant ramifications for hematology. In addition to original research, HemaSphere features review articles and guideline articles that furnish lucid synopses and discussions of emerging developments, along with recommendations for patient care. Positioned as the foremost resource in hematology, HemaSphere augments its offerings with specialized sections like HemaTopics and HemaPolicy. These segments engender insightful dialogues covering a spectrum of hematology-related topics, including digestible summaries of pivotal articles, updates on new therapies, deliberations on European policy matters, and other noteworthy news items within the field. Steering the course of HemaSphere are Editor in Chief Jan Cools and Deputy Editor in Chief Claire Harrison, alongside the guidance of an esteemed Editorial Board comprising international luminaries in both research and clinical realms, each representing diverse areas of hematologic expertise.
期刊最新文献
30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann–Pick disease type C from bone marrow and peripheral blood smears GPRASP protein deficiency triggers lymphoproliferative disease by affecting B-cell differentiation Issue Information Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1